$7.92
-0.08-1%
al cierre: Sep 22, 5:00 PM EST
$8.07
0.151.93%
After hour: Sep 14, 5:49 PM EST
Harvard Bioscience Inc
HBIONASDAQ
Harvard Bioscience Earnings & Forecasts
Harvard Bioscience (HBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harvard Bioscience Guidance
Harvard Bioscience (HBIO) publicó su última previsión de agosto 11, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $89.15M - $90.88M para el período.
En comparación con la previsión anterior, Harvard Bioscience elevado redujo su previsión de ingresos desde un rango anterior de $21M - $22.6M.
Harvard Bioscience ha emitido 16 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 11, 2026. During this period, the company raised its outlook 5 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.03 | $0.30 | $0.10 |
| Actual | $-0.14 | $-0.33 | $0.00 | $0.00 |
| Surprise | +6.67% | -1000.0% | -100.0% | -100.0% |
| Revenue | ||||
| Estimate | $21.4M | $21.2M | $23.1M | $20.0M |
| Actual | $22.7M | $20.8M | $23.7M | $20.6M |
| Surprise | +5.95% | -2.10% | +2.75% | +2.95% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.10 | $0.26 |
| Revenue | ||
| Consensus | $21.8M | $24.5M |